Constantine Davides
Stock Analyst at Citizens
(1.03)
# 3,925
Out of 5,133 analysts
118
Total ratings
30.56%
Success rate
-20.07%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPCH Option Care Health | Reiterates: Market Outperform | $36 → $38 | $34.98 | +8.63% | 8 | Jan 13, 2026 | |
| EVH Evolent Health | Maintains: Market Outperform | $11 → $10 | $4.13 | +142.42% | 12 | Jan 6, 2026 | |
| AMN AMN Healthcare Services | Maintains: Market Outperform | $24 → $22 | $15.82 | +39.06% | 13 | Dec 19, 2025 | |
| HQY HealthEquity | Maintains: Market Outperform | $117 → $122 | $85.48 | +42.72% | 6 | Dec 4, 2025 | |
| PRVA Privia Health Group | Maintains: Market Outperform | $30 → $31 | $24.01 | +29.14% | 5 | Nov 7, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $23 → $24 | $14.11 | +70.09% | 11 | Nov 7, 2025 | |
| WAY Waystar Holding | Initiates: Market Outperform | $48 | $31.18 | +53.97% | 1 | Sep 18, 2025 | |
| ADUS Addus HomeCare | Reiterates: Market Outperform | $150 | $111.10 | +35.01% | 4 | Jul 16, 2025 | |
| SLP Simulations Plus | Reiterates: Market Perform | n/a | $18.91 | - | 2 | Jun 18, 2025 | |
| CERT Certara | Reiterates: Market Perform | n/a | $9.36 | - | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $0.97 | - | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $113 | $84.20 | +34.20% | 2 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $31.38 | -17.14% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $170.39 | +45.55% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $22.46 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $8.43 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $27.98 | - | 3 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.18 | +344.92% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $0.56 | +22,281.38% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $28.55 | -47.46% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $19.32 | +16.46% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $2.92 | +191.33% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.06 | +1,220.75% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $1.18 | +30,408.47% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $1.67 | +193,911.98% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $0.88 | +4,445.45% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.34 | +1,675.15% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,400 → $800 | $1.25 | +63,900.00% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9,960 → $4,980 | $0.50 | +998,096.03% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.30 | +28,233.33% | 2 | Sep 23, 2022 |
Option Care Health
Jan 13, 2026
Reiterates: Market Outperform
Price Target: $36 → $38
Current: $34.98
Upside: +8.63%
Evolent Health
Jan 6, 2026
Maintains: Market Outperform
Price Target: $11 → $10
Current: $4.13
Upside: +142.42%
AMN Healthcare Services
Dec 19, 2025
Maintains: Market Outperform
Price Target: $24 → $22
Current: $15.82
Upside: +39.06%
HealthEquity
Dec 4, 2025
Maintains: Market Outperform
Price Target: $117 → $122
Current: $85.48
Upside: +42.72%
Privia Health Group
Nov 7, 2025
Maintains: Market Outperform
Price Target: $30 → $31
Current: $24.01
Upside: +29.14%
OptimizeRx
Nov 7, 2025
Maintains: Market Outperform
Price Target: $23 → $24
Current: $14.11
Upside: +70.09%
Waystar Holding
Sep 18, 2025
Initiates: Market Outperform
Price Target: $48
Current: $31.18
Upside: +53.97%
Addus HomeCare
Jul 16, 2025
Reiterates: Market Outperform
Price Target: $150
Current: $111.10
Upside: +35.01%
Simulations Plus
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $18.91
Upside: -
Certara
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $9.36
Upside: -
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $0.97
Upside: -
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $84.20
Upside: +34.20%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $31.38
Upside: -17.14%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $170.39
Upside: +45.55%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $22.46
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $8.43
Upside: -
Sep 19, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $27.98
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.18
Upside: +344.92%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $0.56
Upside: +22,281.38%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $28.55
Upside: -47.46%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $19.32
Upside: +16.46%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $2.92
Upside: +191.33%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $1.06
Upside: +1,220.75%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $1.18
Upside: +30,408.47%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $1.67
Upside: +193,911.98%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $0.88
Upside: +4,445.45%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.34
Upside: +1,675.15%
Sep 28, 2022
Maintains: Buy
Price Target: $1,400 → $800
Current: $1.25
Upside: +63,900.00%
Sep 28, 2022
Maintains: Buy
Price Target: $9,960 → $4,980
Current: $0.50
Upside: +998,096.03%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.30
Upside: +28,233.33%